Clinical Application of a Novel Hybrid Intensity-Modulated Radiotherapy Technique for Stage III Lung Cancer and Dosimetric Comparison With Four Other Techniques.
Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.
Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands.
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.
Combining angiogenesis inhibition and radiotherapy: A double-edged sword.
Defining Target Volumes for Stereotactic Ablative Radiotherapy of Early-stage Lung Tumours: A Comparison of Three-dimensional (18)F-fluorodeoxyglucose Positron Emission Tomography and Four-dimensional Computed Tomography.
Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomography.
Pulmonary Toxicity After Bevacizumab and Concurrent Thoracic Radiotherapy Observed in a Phase I Study for Inoperable Stage III Non-Small-Cell Lung Cancer
Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.
Fast Arc Delivery for Stereotactic Body Radiotherapy of Vertebral and Lung Tumors.
Practice guideline 'Brain metastases' (revision).
Reflections on the 14th World Conference on Lung Cancer: A European Perspective.
Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.
The Predictive Value of 3D Time-of-Flight MR Angiography in Assessment of Brain Arteriovenous Malformation Obliteration after Radiosurgery.
The purpose of radiosurgery of bAVMs is complete angiographic obliteration of its nidus.
Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature
Physical Activity Monitoring: A Responsive and Meaningful Patient-Centered Outcome for Surgery, Chemotherapy, or Radiotherapy?
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to register et Al. Int j radiat oncol biol phys 2011;80:1015-1022.
Feasibility of using anatomical surrogates for predicting the position of lung tumours.
Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer.
Patient-focused endpoints in advanced cancer: Criterion-based validation of accelerometer-based activity monitoring.
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study.
Postoperative elective nodal irradiation for squamous cell carcinoma of the head and neck: outcome and prognostic factors for regional recurrence.
Compromised health-related quality of life in patients with low-grade glioma
Outcomes of Stereotactic Ablative Radiotherapy in Patients with Potentially Operable Stage I Non-Small-Cell Lung Cancer.
we studied outcomes after SABR in patients with potentially operable stage I NSCLC.
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: Comparison with a contemporaneous cohort with pathologically proven disease.
Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation
This study investigates the interaction between VPA, TMZ, and c-radiation
Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.
1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer.
Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
Towards tailored therapy of glioblastoma multiforme.
The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms.
MRI and thallium-201 SPECT in the prediction of survival in glioma.
Impact of the calculation resolution of AAA for small fields and RapidArc treatment plans
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.
Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery.
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.
Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy.
Salivary gland function decreases after radiation doses of 39 Gy or higher.
Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer.
Imaging for Stereotactic Spine Radiotherapy: Clinical Considerations.
Curative Treatment of Stage I Non-small-cell Lung Cancer in Patients with Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review
Use of megavoltage cine-images for studying intra-thoracic motion during radiotherapy for locally advanced lung cancer
Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: Outcomes of a markov model analysis
A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer.
Radiotherapy in small-cell lung cancer: lessons learned and future directions.
Brain arteriovenous malformations: from diagnosis to treatment
Stereotactic Radiotherapy: An Emerging Treatment for Spinal Metastases
The Need for Randomized Trials in Mesothelioma: Let's Walk the Talk
Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.
Stereotactic lung radiotherapy: do we need fiducial markers?
Stereotactic lung radiotherapy: do we need fiducial markers?
A new approach to quantifying lung damage after stereotactic body radiation therapy.
Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer.
A novel simple approach for incorporation of respiratory motion in stereotactic treatments of lung tumors.
The accuracy of frameless stereotactic intracranial radiosurgery.
Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non-Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis.
Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity.
Quality Assurance of 4D-CT Scan Techniques in Multicenter Phase III Trial of Surgery Versus Stereotactic Radiotherapy (Radiosurgery Or Surgery for operable Early stage (Stage 1A) non-small-cell Lung cancer [ROSEL] Study).
Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus.
Lung Density Changes After Stereotactic Radiotherapy: A Quantitative Analysis in 50 Patients.
Weekly Chemoradiation (Docetaxel/Cisplatin) Followed by Surgery in Stage III NSCLC; a Multicentre Phase II Study.
Time for reappraisal of extracranial treatment options?: synchronous brain metastases from nonsmall cell lung cancer.
Dosimetric Impact of Interplay Effect on RapidArc Lung Stereotactic Treatment Delivery.
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity.
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool.
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide.
Radiological and Clinical Pneumonitis after Stereotactic Lung Radiotherapy: A Matched Analysis of Three-dimensional Conformal and Volumetric-modulated Arc Therapy Techniques.
Volumetric modulated arc therapy for advanced pancreatic cancer.
Volumetric modulated arc therapy for advanced pancreatic cancer.
Inferring positions of tumor and nodes in Stage III lung cancer from multiple anatomical surrogates using four-dimensional computed tomography.
Radiation oncology: overview and recent advances.
Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment?
Strategies for the analysis of in vitro radiation sensitivity and prediction of interaction with potential radiation modifying agents.
Intracranial radiosurgery in the Netherlands. A planning comparison of available systems with regard to physical aspects and workload.
Clinical outcome after repeated radiosurgery for brain arteriovenous malformations.
RapidArc Planning and Delivery in Patients with Locally Advanced head-and-neck Cancer Undergoing Chemoradiotherapy.
Accelerated Hypofractionated Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: Long-Term Results.
Course of disease and treatment policy in suspected low-grade glioma
Stereotactic radiation therapy for large vestibular schwannomas.
Stereotactic radiation therapy for large vestibular schwannomas.
Clinical outcome after repeated radiosurgery for brain arteriovenous malformations.
Clinical outcome after repeated radiosurgery for brain arteriovenous malformations.
Stereotactic radiotherapy for stage I lung cancer: current results and new developments.
Stereotactic radiotherapy for stage I lung cancer: current results and new developments.
Ipsilateral Irradiation for Oral and Oropharyngeal Carcinoma Treated With Primary Surgery and Postoperative Radiotherapy.
New developments in arc radiation therapy: a review.
Volumetric modulated arc therapy versus conventional intensity modulated radiation therapy for stereotactic spine radiotherapy: a planning study and early clinical data.
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.
Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy.
Radiotherapy for extensive stage small cell lung cancer.
PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings?
A study on the influence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT.
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al.
Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.
Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy.
Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs.
Volumetric modulated arc radiotherapy for vestibular schwannomas.
Volumetric modulated arc radiotherapy for vestibular schwannomas.
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III ...
The relationship of histological tumor regression grade (TRG) and two different time intervals to surgery following radiation therapy for locally advanced rectal cancer.
Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Role of adaptive radiotherapy during concomitant chemoradiotherapy for lung cancer: analysis of data from a prospective clinical trial.
An evaluation of two internal surrogates for determining the three-dimensional position of peripheral lung tumors.
Comments on 'Single-Arc IMRT?'.
Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancer.
Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence.
Imaging-documented repeated intratumoral hemorrhage in vestibular schwannoma: a case report.
Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy.
A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer.
A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer.
Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study.
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies.
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
Evaluation of four-dimensional computed tomography-based intensity-modulated techniques and respiratory-gated radiotherapy techniques for pancreatic carcinoma.
Radiotherapy for lung cancer: Clinical impact of recent technical advances.
Radiotherapy for lung cancer: Clinical impact of recent technical advances.
Impact of late treatment-related toxicity on quality of life among patients with head an neck cancer treated with Radiotherapy.
Health-related quality of life of long-term high-grade glioma survivors.
Health-related quality of life of long-term high-grade glioma survivors.
Impact of audio-coaching on the position of lung tumors
Analysis of carina position as a surrogate marker for delivering phase-gated radiotherapy
Analysis of carina position as a surrogate marker for delivering phase-gated radiotherapy
Reproducibility of quantitative (18)F-3’-deoxy-3’-fluorothymidine measurement using positron emission tomography
Linear accelerator-based stereotactic radiosurgery for bilateral vestibular Schwannomas in patients with neurofibromatosis Type 2.
Analysis of reproducibility of respiration-triggered gated Radiotherapy for lung tumors
Analysis of reproducibility of respiration-triggered gated Radiotherapy for lung tumors
Palliative-care trials: How best to publish findings?
Tumor-volume changes after radiosurgery for vestibular Schwannoma: Implications for follow-up MR imaging protocol
Radiosurgery of brain arteriovenous malformations in children
Radiosurgery of brain arteriovenous malformations in children
Critical review of non-surgical treatment options for stage I non-small cell lung cancer
Critical review of non-surgical treatment options for stage I non-small cell lung cancer
Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer
Re-irradiation of a second localization of idiopathic midline destructive disease in the head and neck area
Differential Radiosensitizing Potential of Temozolomide in MGMT Promoter Methylated Glioblastoma Multiforme Cell Lines.
A four-dimensional CT-based evaluation of techniques for gastric irradiation
Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2'-deoxy-2'-[(18)F]fluoro-D: -glucose (FDG) and 3'-[ (18)F]fluoro-3'-deoxythymidine (FLT).
Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer
Global robust stability of bidirectional associative memory neural networks with multiple time delays
Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva
Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer
Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration
Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells
Verifying 4D gated radiotherapy using time-integrated electronic portal imaging: a phantom and clinical study
Prophylactic cranial irradiation in extensive small-cell lung cancer
Staging nodal disease in non-small cell lung cancer: implications for radiation therapy.
Can mediastinal nodal mobility explain the low yield rates for transbronchial needle aspiration without real-time imaging?
Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery.
External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy.
Design of clinical trials of radiation combined with antiangiogenic therapy.
Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?
Color intensity projection of digitally subtracted angiography for the visualization of brain arteriovenous malformations.
Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration.
Lung cancer: intensity-modulated radiation therapy, four-dimensional imaging and mobility management.
Delineation of brain AVMs on MR-Angiography for the purpose of stereotactic radiosurgery.
The course of neurocognitive functioning in high-grade glioma patients.
Comment on: Case 21-2006: a man with left-side facial pain.
Genetic profiling of a distant second glioblastoma multiforme after radiotherapy: Recurrence or second primary tumor?
Reproducibility of target volumes generated using uncoached 4-dimensional CT scans for peripheral lung cancer.
Angiogenesis-independent tumor growth mediated by stem-like cancer cells.
Thalidomide in refractory haemorrhagic radiation induced proctitis.
Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy.
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer.
Evaluating mobility for radiotherapy planning of lung tumors: A comparison of virtual fluoroscopy and 4DCT
Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.
A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer.
Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy.
Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.
A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
Color intensity projections: A rapid approach for evaluating 4-dimensional CT scans in treatment planning.
Renal mobility during uncoached quiet respiration: an analysis of 4DCT scans.
The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy.
Neuroblastoma
Introduction In Extracranial Stereotactic Radiotherapy and radiosurgery.
Extracranial stereotactic radiotherapy and radiosurgery.
Cancers of the Thorax.
4D imaging for target definition in stereotactic radiotherapy for lung cancer.
Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue.
Critical review of PET-CT for radiotherapy planning in lung cancer.
Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.
Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration.
COX-2 inhibitors act as radiosensitizer in tumor treatment.
Lymphatic fistulas: obliteration by low-dose radiotherapy.
Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy
In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2005;62:255-259).
Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC.
Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme.
Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer.
Speech outcome after surgical treatment for oral and oropharyngeal cancer: a longitudinal assessment of patients reconstructed by a microvascular flap.
Effects of hyperthermia on the central nervous system: what was learnt from animal studies?
Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.
Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1.
Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.
Stereotactic radiosurgery for brain AVMs: role of interobserver variation in target definition on digital subtraction angiography.
Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction.
A review on re-irradiation for recurrent and second primary head and neck cancer.
Hyperbaric oxygen and radiotherapy.
Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961.
Oncolytic virotherapy of meningiomas in vitro with replication-competent adenovirus.
Clinical use of four-dimensional computed tomography scans
The role of radiotherapy in non-small-cell lung cancer.